Brain Structural and Functional Connectome in HIV-associated Neuroinflammation

HIV 相关神经炎症中的脑结构和功能连接组

• 批准号: 9918468
• 负责人: GIOVANNI SCHIFITTO
• 金额: $ 55.38万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-07-20 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9918468
• 关键词: Address; Affect; Age; Aging; Anti-Retroviral Agents; Behavior; Blood Coagulation Disorders; Brain; Brain region; CD14 gene; Cells; Cerebral small vessel disease; Cerebrovascular Disorders; Cerebrum; Clinical; Coagulation Process; Cognitive; Corpus striatum structure; Demyelinations; Diffuse; Diffusion Magnetic Resonance Imaging; Evolution; Fibrin fragment D; Funding; Gender; HIV; HIV Infections; HIV Seronegativity; HIV-associated cognitive impairment; Image; Immune; Impaired cognition; Individual; Inflammation; Inflammatory; Injury; Ischemia; Lead; Liquid substance; Longitudinal cohort; Magnetic Resonance Imaging; Measurement; Measures; Mediating; Mediation; Methodology; Methods; Microcirculation; Monitor; Neuraxis; Neurocognitive Deficit; Neurons; Older Population; Participant; Physiologic pulse; Play; Population; Positioning Attribute; Recovery; Reporting; Research Proposals; Risk; Role; Structure; Targeted Research; Thick; Thromboplastin; Toxic effect; United States National Institutes of Health; Vascular Diseases; Viral; White Matter Hyperintensity; antiretroviral therapy; attenuation; base; brain abnormalities; central nervous system injury; clinical imaging; cohort; comorbidity; connectome; cost; follow-up; gray matter; immune activation; improved; monocyte; neuroimaging; neuroinflammation; neuronal circuitry; novel; novel strategies; therapeutic target; vascular risk factor; white matter

Abstract: With an aging HIV population, it is becoming increasingly difficult to disentangle central nervous system (CNS) injury due to HIV from that due to comorbidities such as vascular disease. A commonality between HIV infection and aging is that both can be considered inflammatory conditions; thus HIV and aging can be expected to have an additive, if not synergistic, negative effect on the CNS. The driver of CNS injury in HIV infected individuals on combination antiretroviral therapy (cART) is likely multifactorial, and may include HIV viral products, antiretrovirals CNS toxicity, traditional vascular risk factors and persistent CNS immune activation. Pro-inflammatory monocytes, such as those expressing tissue factor (TF+), are well-positioned to mediate both inflammation and coagulopathy, thus likely to play a role in CNS injury. TF+ monocytes are increased in HIV+ individuals, even in those on effective cART. Their ability to mediate both inflammation and coagulopathy can lead to dysregulation of the CNS microcirculation, followed by ischemia, and then to demyelination. This last effect is visible as white matter hyperintensities (WMH) in standard clinical MRI studies, for example FLAIR sequence. More advanced pulse sequences, such as diffusion weighted imaging, can provide quantitative measurements of abnormal white matter microstructure integrity even when there is no visible WMH on FLAIR. Well-treated HIV+ individuals are expected to have a very slow neurocognitive decline which is also reflected in small, neuroimaging changes overtime. Therefore, it may take several years for those imaging changes reflecting CNS injury to become quantifiable with standard methodology. We propose novel methodologies that reproducibly construct structural and functional connectomes across subjects and between populations, thus further improving our understanding in the evolution of HIV-associated CNS injury. These novel methods are based on a rigorous statistical approach which will provide the reliability needed to ascertain small changes overtime. We propose to implement these methodologies while investigating the role of TF+ monocytes, immune cells at the crossroad of inflammation and coagulopathy, thus likely involved in HIV-associated CNS injury, especially in an older population. The specific aims listed below will be investigated in a three-year longitudinal cohort of 110 HIV+ participants and 110 HIV- age, gender and vascular risk factors matched controls. We have chosen a cohort that is primarily composed of participants age ≥50 thus at greater risk of vascular disease. Aim 1. To assess via novel methodologies the longitudinal changes in the trajectory of brain structural connectome and functional connectivity in HIV infected compared to HIV seronegative individuals in the context of intermediaries of inflammation and coagulopathy (soluble CD14 and CD163, D-dimer, soluble tissue factor and TF+ monocytes). Aim 2. To assess the mediation effect of structural connectome, functional connectivity and cerebral cortical thickness on specific cognitive domains.

文摘: